Li, C. (2026). Should CRISPR-Cas9 Be Used in Human Embryos to Eliminate Genetic Diseases? Public Attitudes and Benefit–Risk Analysis. MedScien, 4(1), 6812. https://doi.org/10.61173/as39n470